Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway

Journal of Lipid Research

Volumn 44, Issue 4, 2003, Pages 828-836

  Remaley, Alan T ^a   Thomas, Fairwell ^a   Stonik, John A ^a   Demosky, Steve J ^a   Bark, Samantha E ^a   Neufeld, Edward B ^a   Bocharov, Alexander V ^b   Vishnyakova, Tatyana G ^a   Patterson, Amy P ^a   Eggerman, Thomas L ^b   Santamarina Fojo, Silvia ^a   Brewer, H Bryan ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Apolipoprotein A I; ATP binding cassette transporter; High density lipoprotein

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; AMINO ACID; APOLIPOPROTEIN A1; CHOLESTEROL; DEXTRO AMINO ACID; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HIGH DENSITY LIPOPROTEIN; LIPID; PARAFORMALDEHYDE; PEPTIDE; PHOSPHOLIPID; PROLINE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENERGY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LIPID TRANSPORT; LIPID VESICLE; PASSIVE TRANSPORT; PEPTIDE SYNTHESIS; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; SOLUBILIZATION; STEREOCHEMISTRY; TANGIER DISEASE;

ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; HELA CELLS; HUMANS; KINETICS; LIPID METABOLISM; LIPIDS; MODELS, BIOLOGICAL; PEPTIDES; PHOSPHOLIPIDS; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY; STEREOISOMERISM; SURFACE-ACTIVE AGENTS; TRANSFECTION;

EID: 10744232793     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200475-JLR200     Document Type: Article

References (37)

1. Dean, M., Y. Hamon, and G. Chimini. 2001. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42: 1007-1017.
2. Langmann, T., J. Klucken, M. Reil, G. Liebisch, M-F. Luciani, G. Chimini, W. E. Kaminski, and G. Schmitz. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257: 29-33.
3. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491.
4. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. Brewer, N. Duverger, P. Denefle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355.
5. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
6. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, and M. R. Hayden. 1999. Mutations in ABC1 in tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
7. Remaley, A. T., M. Rosier, C. Knapper, K. M. Peterson, C. Koch, M. Dinger, N. Duverger, G. Assman, M. Dean, S. Santamarina-Fojo, D. S. Fredrickson, P. Denefle, and H. B. Brewer, Jr. 1999. Human ATP binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original tangier disease kindred. Proc Natl. Acad. Sci. USA. 96: 12685-12690.
8. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porte, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
9. Assmann, G., A. von Eckardstein, and H. B. Brewer, Jr. 1995. Familial high density lipoprotein deficiency: Tangier disease. In The Metabolic and Molecular Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D.Valle, editors. McGraw Hill, New York. 2053-2072.
10. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-1 in Tangier disease. J. Clin. Invest. 96: 78-87.
11. Remaley, A. T., U. K. Schumacher, J. A. Stonik, B. D. Farsi, H. Nazih, and H. B. Brewer, Jr. 1997. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17: 1813-1821.
12. Wang, N., D. L. Silver, P. Costet, and A. R. Tall. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275: 33053-33058.
13. Hamon, Y., C. Broccardo, O. Chambenoit, M. F. Luciani, F. Toti, S. Chaslin, J. M. Freyssinet, P. F. Devaux, J. McNeish, D. Marguet, and G. Chimini. 2000. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2: 399-406.
14. Remaley, A. T., J. A. Stonik, S. J. Demosky, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, T. L. Eggerman, A. P. Patterson, N. Duverger, S. Santamarina-Fojo, and H. B. Brewer. 2001. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280: 818-823.
15. Oram, J. F., R. M. Lawn, M. R. Garvin, and D. P. Wade. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508-34511.
16. Segrest, J. P., M. K. Jones, H. D. Loof, C. G. Brouillette, Y. V. Venkatachalapathi, and G. M. Anantharamaiah. 1992. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid Res. 33: 141-166.
17. Anantharamaiah, G. M., J. L. Jones, C. G. Brouillette, C. F. Schmidt, B. H. Chung, T. A. Hughes, A. S. Brown, and J. P. Segrest. 1985. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J. Biol. Chem. 260: 10248-10255.
18. Chambenoit, O., Y. Hamon, D. Marguet, H. Rigneault, M. Rosseneu, and G. Chimini. 2001. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276: 9955-9960.
19. Fukushima, D., S. Yokoyama, D.J. Kroon, F. J. Kezdy, and E. T. Kaiser. 1980. Chain length-function correlation of amphiphilic peptides. J. Am. Chem. Soc. 101: 3703-3704.
20. Navab, M., G. M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman. 2002. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 105: 290-292.
21. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
22. Yancey, P. G., K. Bielicki, W.J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. Segrest, M. C. Phillips, and G. H. Rothblatt. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 34: 7955-7965.
23. Epand, R. M., A. Gawish, M. Iqbal, K. B. Gupta, C. H. Chen, J. P. Segrest, and G. M. Anantharamaiah. 1987. Studies of synthetic peptide analogs of the amphipathic helix. J. Biol. Chem. 262: 9389-9396.
24. Gillotte, K. L., M. Zaiou, S. Lund-Katz, G. M. Anantharamaiah, P. Holvoet, A. Dhoest, M. N. Palgunachari, J. P. Segrest, K. H. Weisgraber, G. H. Rothblatt, and M. C. Phillips. 1999. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J. Biol. Chem. 274: 2021-2028.
25. Gillotte, K. L., W. S. Davidson, S. Lund-Katz, G. H. Rothblatt, and M. C. Phillips. 1998. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J. Lipid Res. 39: 1918-1928.
26. Takahashi, Y., M. Miyata, P. Zheng, T. Imazato, A. Horwitz, and J. D. Smith. 2000. Identification of cAMP analogue inducible genes in RAW264 macrophages. Biochim. Biophys. Acta. 2000 1492: 385-394.
27. Leppimank, P., J. Mattinen, and J. P. Slotte. 2000. Sterol-induced upregulation of phosphatidylcholine synthesis in cultured fibroblasts is affected by the double-bond position in the sterol tetracyclic ring structure. Eur. J. Biochem. 267: 6385-6394.
28. Tabas, I., S. Marathe, G. A. Keesler, N. Beatini, and Y. Shiratori. 1996. vidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis. Proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis. J. Biol. Chem. 271: 22773-22781.
29. Jonas, A. 1986. Reconstitution of high-density lipoproteins. Methods Enzymol. 128: 553-581.
30. Chen, Y., C. T. Mant, and R. S. Hodges. 2002. Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix. J. Pept. Res. 59: 18-33.
31. Hay, R. E., W. D. Woods, R. L. Church, and J M. Petrash. 1987. cDNA clones encoding bovine gamma-crystallins. Biochem. Biophys. Res. Commun. 146: 332-338.
32. Mendez, A. J. 1997. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38: 1807-1821.
33. Gillotte-Taylor, K., M. Nickel, W. J. Johnson, O. L. Francone, P. Holvoet, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2002. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J. Biol. Chem. 277: 11811-11820.
34. Trigatti, B. L., A. Rigotti, and A. Braun. 2000. Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim. Biophys. Acta. 1529: 276-86.
35. Panagotopulos, S. E., S. R. Witting, E. M. Horace, D. Y. Hui, J. N. Maiorano, and W. S. Davidson. 2002. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1). J. Biol. Chem. 277: 39477-39484.
36. Palgunachari, M. N., V. K. Mishra, S. Lund-Katz, M. C. Phillips, S. O. Adeyeye, S. Alluri, G. M. Anantharamaiah, and J. P. Segrest. 1996. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb. Vasc. Biol. 16: 328-338.
37. Mishra, V. K., M. N. Palgunachari, G. Datta, M. C. Phillips, S. Lund-Katz, S. O., Adeyeye, J. P. Segrest, and G. M. Anantharmiah 1998. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. Biochemistry. 37: 10313-10324.